These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Effect of inhibition of telomerase activity on cisplatin-induced apoptosis in K562 cells].
    Author: He D, Zhang H.
    Journal: Zhonghua Xue Ye Xue Za Zhi; 2001 Jul; 22(7):355-8. PubMed ID: 11877097.
    Abstract:
    OBJECTIVE: To explore the effect of human telomerase reverse transcriptase (hTERT) gene antisense oligodeoxynucleotide (ASODN) on telomerase activity and cisplatin-induced apoptosis in K562 cells. METHODS: Telomerase activity was analyzed by using polymerase chain reaction enzyme-linked immunoassay (PCR-ELISA), expression levels of hTERT protein by immunofluorescence and apoptosis by DNA gel electrophoresis and flow cytometry. RESULTS: There was a marked decrease in both the percentage of hTERT protein positive cells and the telomerase activity in ASODN treated cell as compared with that in control and sense oligodeoxynucleotide (SODN)-treated cells; but no difference between the latter two groups. Agarose gel electrophoresis of genomic DNA from K562 cells treated with ASODN and cisplatin combination for 72 h showed typical DNA ladder; neither did DNA from K562 cells treated with SODN plus cisplatin nor cisplatin alone. Apoptosis rates of K562 cells treated with ASODN for 24 h and then with cisplatin for 72 h were significantly increased. There was statistically significant difference in the percentage of apoptotic cells between hTERT ASODN plus cisplatin group and SODN plus cisplatin or cisplatin alone group. CONCLUSION: The hTERT gene ASODN could inhibit telomerase activity of K562 cells whereby it enhanced cisplatin-induced apoptosis of the cells.
    [Abstract] [Full Text] [Related] [New Search]